Submission Details
| 510(k) Number | K251391 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 05, 2025 |
| Decision Date | November 07, 2025 |
| Days to Decision | 186 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K251391 is an FDA 510(k) clearance for the BrainsWay Deep TMS System, a Transcranial Magnetic Stimulator (Class II — Special Controls, product code OBP), submitted by Brainsway , Ltd. (Jerusalem, IL). The FDA issued a Cleared decision on November 7, 2025, 186 days after receiving the submission on May 5, 2025. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5805.
| 510(k) Number | K251391 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 05, 2025 |
| Decision Date | November 07, 2025 |
| Days to Decision | 186 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | OBP — Transcranial Magnetic Stimulator |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5805 |
| Definition | A Transcranial Magnetic Stimulator Is A Device That Delivers Brief Duration, Rapidly Alternating, Or Pulsed, Magnetic Fields To Induce Electrical Currents That Are Directed At Spatially Discrete Regions Of The Cerebral Cortex For The Treatment Of Major Depressive Disorder. |